Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Kučerová, Helena
2003.
Olanzapina y mejoría de la discinesia tardía.
European psychiatry (Ed. Española),
Vol. 10,
Issue. 4,
p.
266.
Bai, Ya-Mei
Yu, Shun-Chieh
Chen, Jen-Yeu
Lin, Chih-Yuan
Chou, Pesus
and
Lin, Chao-Cheng
2005.
Risperidone for pre-existing severe tardive dyskinesia: a 48-week prospective follow-up study.
International Clinical Psychopharmacology,
Vol. 20,
Issue. 2,
p.
79.
Pierre, Joseph M
2005.
Extrapyramidal Symptoms with Atypical Antipsychotics.
Drug Safety,
Vol. 28,
Issue. 3,
p.
191.
Echater, S.
Oneib, B.
and
Saiz-Ruiz, Jeronimo
2023.
Improvement of Tardive Dyskinesias with Olanzapine.
Case Reports in Psychiatry,
Vol. 2023,
Issue. ,
p.
1.
Ibragimov, Khasan
Keane, Gregory Peter
Carreño Glaría, Cristina
Cheng, Jie
and
Llosa, Augusto Eduardo
2024.
Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders.
Cochrane Database of Systematic Reviews,
Vol. 2024,
Issue. 7,
Comments
No Comments have been published for this article.